Skip to main content

Prime Medicine, Inc 8-K, filed Nov 12, 2026

Prime Medicine, Inc. (PRME)

8-K 2026-11-12 For: 2026-11-10
View Original
Added on November 12, 2026

About this 8-K

Prime Medicine, Inc filed this 8-K on November 12, 2026, reporting on events of November 10, 2026.

Prime Medicine priced 35,714,286 shares at $3.50 per share and granted underwriters an option for 5,357,142 additional shares. Estimated net proceeds, including full option exercise and after underwriting discounts, commissions and offering expenses, are approximately $134.7 million. AI summary

Items reported

  • Item 1.01: Entered into a material agreement